IBI-306

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI-306, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia [Phase 3]